Researchers at Texas A&M University have identified a protective brain pathway that may help slow the progression of Parkinson’s disease by strengthening the brain’s dopamine-producing neurons. The study, published in the *Journal of Neuroscience*, found that enhancing nicotine-responsive receptors without using nicotine itself preserved these neurons in female models, while no similar effects were observed in males. Dr. Rahul Srinivasan, an associate professor of neuroscience, emphasized the importance of keeping neurons alive longer to slow disease advancement. Current treatments mainly manage symptoms rather than halting neuron loss, making this discovery significant for future therapies. The study also highlights the role of biological sex in how neurons respond to damage, suggesting that treatments may need to be tailored accordingly. Overall, the findings point towards a potential shift in Parkinson’s treatment strategies, focusing on preserving neuronal function rather than merely compensating for their loss.